Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.

Antzeko izenburuak

• Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis.
  nork: Stephen C Graham, et al.
  Argitaratua: (2008-08-01)
• Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB.
  nork: Benfield, C, et al.
  Argitaratua: (2011)
• Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
  nork: Bahar Miraghazadeh, et al.
  Argitaratua: (2018-04-01)
• NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
  nork: Smith, C, et al.
  Argitaratua: (2001)
• Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
  nork: Andreakos, E, et al.
  Argitaratua: (2006)